A new agent for the treatment of lymphoid neoplasias

  • The present invention claims the use of a micro RNA (miR-28) for the treatment of mature B cell neoplasias, including Burkitt lymphoma (BL), diffuse large B cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). The patent application also claims different miRNA compositions, as well as compounds that mimic the miRNA activity of miR-28, including pharmaceutically acceptable carriers and the route of administration.

    Number
    EP15382249
    Priority date
    14/05/2015
    Aplicants
    CNIC
    Inventors
    Almudena Rodríguez Ramiro, Nahikari Bartolomé izquierdo, Virginia García de Yébenes Mena